echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Hairpin Ribozyme Gene Therapy for AIDS

    Hairpin Ribozyme Gene Therapy for AIDS

    • Last Update: 2021-01-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Acquired immune deficiency syndrome (AIDS) is a deadly disease that is the pathological consequence of infection with human immunodeficiency virus (HIV). The virus is spread via body fluids, and infection results in progressive immune dysfunction, most notably a loss of CD4
    +
    cells, leading to a myriad of opportunistic infections and maladies. In spite of public education efforts that were expected to control the epidemic, the virus continues to spread, emphasizing that a means to battle the disease is mandatory. Despite extensive efforts by researchers around the world, an effective vaccine or chemotherapy drug has not been developed for preventing this deadly disease, nor is one expected in the foreseeable future. This failure of conventional methods indicates that more novel approaches need to be explored.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.